Evidence map›Paper›PMID 33092225›Full record

ArticleFoods (Basel, Switzerland)2020

Optimization of the Enzymatic Protein Hydrolysis of By-Products from Seabream (

Jesus Valcarcel, Noelia Sanz, José Antonio Vázquez

Open access · goldAbstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jesus ValcarcelMarine Biotechnology and Bioprocesses Group, Marine Research Institute (IIM-CSIC), Eduardo Cabello 6, 36208 Vigo, Spain.ORCID 0000-0001-7336-4049
Noelia SanzMarine Biotechnology and Bioprocesses Group, Marine Research Institute (IIM-CSIC), Eduardo Cabello 6, 36208 Vigo, Spain.
José Antonio VázquezMarine Biotechnology and Bioprocesses Group, Marine Research Institute (IIM-CSIC), Eduardo Cabello 6, 36208 Vigo, Spain.ORCID 0000-0002-1122-4726

Funding

Xunta de Galicia IN607B 394 2018/19
6 · The paper itself

Abstract

Valorization of seabass and seabream by-products is becoming increasingly relevant, as marketing of these species moves from selling whole fish to filleting for convenience products. With this aim, we optimized for the first time the production of fish protein hydrolysates (FPH) by enzymatic hydrolysis from filleting by-products of these commercially relevant aquaculture species, isolating fish oil at the same time. On the whole, both fish yielded similar amounts of protein, but frames and trimmings (FT) were the best source, followed by heads and viscera. In vitro antioxidant and antihypertensive activities showed similar figures for both species, placing FPHs from FT as the most active. Molecular weights ranged from 1381 to 2023 Da, corresponding to the lowest values of FT, in line with the higher hydrolysis degrees observed. All FPHs reached high digestibility (>86%) and displayed an excellent amino acid profile in terms of essential amino acids and flavor, making them suitable as food additives and supplements.

Indexed as

bioactiveDicentrarchus labraxfish protein hydrolysatesmathematical optimizationseabream and seabass by-product valorizationSparus aurata

Identifiers

PMID33092225
PMCPMC7589672
OpenAlexW3094045289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.